key: cord-0728834-llucpq0e
authors: Arend, Peter
title: Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates
date: 2020-11-04
journal: Immunobiology
DOI: 10.1016/j.imbio.2020.152027
sha: bd0490da1facedc0dfb956b36d693093cdf4453a
doc_id: 728834
cord_uid: llucpq0e

While the angiotensin converting enzyme 2 (ACE2) protein is defined as the primary severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, the viral serine molecule might be mobilized by the host's transmembrane protease serine subtype 2 (TMPRSS2) enzyme from the viral spike (S) protein and hijack the host’s N-acetyl-D-galactosamine (GalNAc) metabolism. The resulting hybrid, serologically A-like/Tn (T-nouvelle) structure potentially acts as a host–pathogen functional molecular bridge. In humans, this intermediate structure will hypothetically be replaced by ABO(H) blood group-specific, mucin-type structures, in the case of infection hybrid epitopes, implicating the phenotypically glycosidic accommodation of plasma proteins. The virus may, by mimicking the synthetic pathways of the ABO(H) blood groups, bind to the cell surfaces of the blood group O(H) by formation of a hybrid H-type antigen as the potential precursor of hybrid non-O blood groups, which does not affect the highly anti-glycan aggressive anti-A and anti-B isoagglutinin activities, exerted by the germline-encoded nonimmune immunoglobulin M (IgM). In the non-O blood groups, which have developed from the H-type antigen, these IgM activities are downregulated by phenotypic glycosylation, while adaptive immunoglobulins might arise in response to the hybrid A and B blood group structures, suggesting the exertion of autoreactivity. The non-O blood groups thus become a preferred target for the virus, whereas blood group O(H) individuals, lacking the A/B phenotype-determining enzymes and binding the virus alone by hybrid H-type antigen formation, have the least molecular contact with the virus and maintain the critical anti-A and anti-B isoagglutinin activities, exerted by the ancestral IgM, which is considered the humoral spearhead of innate immunity.

Using a translational study, Preece et al. (2002) (Oostra et al., 2006) and is currently predicted for SARS-CoV-2 or COVID-19 (Andersen et al., 2020) , would implicate the formation of hybrid, serologically A-like, O-GalNAcα1-Ser/Thr-R, Tn antigenic structures (Arend, P., 2020a) .

This prediction is not consistent with the concept of Guillon et al. (2008) which presents that these viruses bind to hosts using N-glycosylation. They found that the interaction between the viral S protein of SARS-CoV-1 and the host's cellular receptor was inhibited by natural and monoclonal anti-A antibodies. However, the most critical step in SARS-CoV-2 infection appears to be the mobiliza-tion of the viral serine molecule (Matsuyama et al., 2010; Hoffmann et al., 2020) , which represents the key molecule of the classical O-glycan structure. This may strongly suggest that apart from functional N-glycosylation, the O-glycoproteome of the host plays a key role in the pathogenesis of SARS-CoV-2. Thus, the adhesion of the virus to host cells appears to primarily occur independently of the ABO(H) blood group via the genetically undefined intermediate, namely the serologically A-like/Tn evolutionary/developmental structure. This structure is common to all processes of metazoan development and/or ontogeny, and its hybridized form apparently acts as a host-pathogen functional bridge in different, unrelated infectious diseases (Arend, P., 2018b; 2020b) . In fact, the ACE2 protein is defined as the primary SARS-CoV-2 receptor and evidence suggests the host and pathogen bind via an intermediate hybrid O-glycan, dominated by the pathogen's hydrophilic amino acid serine. In humans, this ontogenetic and blood group-independent structure may, depending on the phenotype, be elongated and/or replaced by mucin-type, blood group-specific, ABO(H) phenotype-determining carbohydrates according to established pathways (Vitiazeva et al., 2015) .

The coevolution of species drives diversity in animals and plants and contributes to natural selection; however, during an infectious disease outbreak, a pathogen may complete an incomplete evolutionary/developmental function by utilizing the host cell's machinery (Arend, P, 2020b) . The analysis of older, yet related, data suggests that Plasmodium falciparum, the pathogen causing malaria, cannot survive outside its human host because it is unable to initiate protein glycosylation or blood group-independent (serologically A-like) O-Gal-NAcα1-Ser/Thr-R, Tn antigen formation, owing to its inability to synthesize the amino sugar N-acetyl-D-galactosamine (GalNAc) (Dieckmann-Schuppert, Bause and Schwarz, 1993) , nor does it possess the genes required for mucin-type O-glycan synthesis (Templeton et al., 2004) .

Although the pathogenesis of a non-viral infection cannot be compared to that of a viral infection, the following data strongly suggests that SARS-CoV-2 invades the human cell by forming an intermediate (Inoue et al., 2007) and, after the subsequent cleavage of the ACE-viral S protein complex by cathepsin L (Simmons et al., 2005) , the virus enters the cell by receptor-mediated endocytosis (Wang et al., 2008) . Regarding which amino acids dominate the host-pathogen fusion process, the most critical molecular step appears to be the mobilization of the viral serine molecule which is performed by the host protease TMPRSS2 (Matsuyama et al., 2010; Hoffmann et al., 2020) . The history of this hydrophilic amino acid and its essential involvement in the pathogenesis of SARS-CoV-2 strongly suggest that the binding between pathogen and host occurs via O-glycosylation. Although serine-rich repeat proteins (SRRPs) that are involved in the adhesion of different bacteria (Latousakis et al., 2020) to host cell carbohydrates via O-glycosylation have not yet been described for the pathogenesis of viral infections, such a mechanism might occur in the pathogenesis of SARS-CoV infections.

Moreover, the inhibition of the TMPRSS2 enzyme or the blocking of serine mobilization could be therapeutic strategies against the influenza virus (Meyer et al., 2013) and SARS-CoV-2 .

Based on observations, inhibiting the interaction between the viral S protein and the host cell receptor by natural and monoclonal anti-A antibodies (Guillon et al., 2008) might strongly inhibit O-glycan formation. Furthermore, when the most critical molecular step in the pathogenesis of SARS-CoV-2 appears to be the mobilization of the viral serine molecule, the preferential occurrence of severe symptoms in individuals with non-O blood groups suggests that the phenotypedetermining saccharides of blood group A and B are the glycosidic targets of serine residues. These residues are preserved on the viral S protein and become available through the action of the host protease TMPRSS2. Apart from functional peptide formations, the essential binding between host and pathogen might not result in a hybrid peptide but an intermediate hybrid O-glycan; the ACE2 receptor protein, assumingly codetermined by the ABO(H) phenotype (Cidl et al., 1996; Gassó et al., 2014; Terao et al., 2013) , would mediate the activities of the ABO(H) glycan-transferring enzymes to achieve blood group A-and/or B-specific mucin-type (O-glycosidic), hybrid binding.

Humoral innate immunity, or the first line of defense, and its complex connection with ABO(H) phenotype formation are considered to play the main role in SARS-CoV-2 infection and in the course of subsequent disease. In contrast to adaptive, environmentally-induced immunoglobulin or B-cell activities, which are controlled by clonal selection, the production of the nonimmune and polyreactive IgM is not restricted to B cells, but spontaneously occurs in murine (Zhou, O'Hara and Chen, 2011; Shao et al., 2016) and human (F. Hu et al., 2012a) normal and malignant epithelial cells as well. The early ovariectomy of the C57BL/10 inbred mouse (Arend and Nijssen, 1976; 1977a; 1977b) may have revealed that in the mammalian species this IgM molecule is a germline-encoded antibody, which is, through a complex evolutionary process, structurally connected with the ancestral A-like/Tn antigen (detected in water-soluble ovarian glycolipids) and is considered its complementary protein (Arend, P, 2016; P., 2017) . Although Larkin and Porter (2005) render the mouse an unsuitable model of the ABO(H)-phenotype discordance in primates, the murine nonimmune IgM has, in the presence of complement, lysed human RBC like an anti-A isoantibody and has even distinguished between the subgroups A 1 and A 2 (Arend and Nijssen, 1977a ).

The human nonimmune IgM molecule is a polyreactive antibody, which undergoes the ABO(H) blood group phenotype formation, occurring on both the cell surfaces and plasma proteins. Serine residues as detected in neonatal IgM sequencing (Willis et al, 2013) and located at the Fc-region (Wang et al. 2016 ) might play the key role in phenotypical accommodation of autoreactive antibody activities. The metabolic centre of this hypothetical process could be a blood groupactive soluble plasma protein, such as the α2-macroglobulin molecule, whose ABO(H) blood group activity correlates strictly with the phenotype (Matsui et al., 2001) . This molecule is considered an evolutionarily conserved arm of the innate immune system (Armstrong and Quigley, 1999) and shows a functional synergism with the structurally related IgM molecule (Stevenson et al., 2015) . This molecule will glycosidically be tailored to the phenotypic specificities (Arend, P., 2016; 2017; 2018b) (Fig. 1) .

The process of viral ABO(H) blood group hybridization, mimicking the syngeneic epitopes as the target of this hybridization, is illustrated in Fig. 2 : blood group O(H), which is bound to the virus solely by the formation of the hybrid H-type antigen, has the least contact with the pathogen and is the most protected group when it loses only the anti-H isoagglutinin, but retains the innate anti-A and anti-B isoagglutinin reactivities, involving secondary IgG responses.

In the blood group A, the anti-A and anti-H formations are physiologically blocked, while the anti-B shows a reduced level and neither anti-A-nor anti-B-reactive IgG is produced in this group due to clonal selection (Arend and Fehlhaber, 1969; Arend, P., 2016; 2017; 2018b) . In blood group B, the anti-B and anti H-reactivities are blocked respectively, while the anti-A shows a reduced level, as the anti-B in blood group A and neither anti-A nor anti-B-reactive IgG is produced in these blood groups. Blood group AB has the strongest contact to pathogen and is the least protected group with respect to innate ABO(H) immunity. It is assumed that during SARS-CoV-2 infection, especially in the non-O blood groups, the induction of autoimmune processes might contribute to the development of severe symptoms, which may even be dominated by autoimmune inflammation. In fact, this phenomenon has been observed in severe cases of malaria tropica (Hart et al., 2016; Rivera-Correa et al., 2017) . It has been explained by the author through hybridization (Arend, 2020b) , but awaits elucidation through studies of the complex mechanisms of cellular immunity, which is ignored in this manuscript that exclusively is focused on the ABO(H) blood group phenotype-determined humoral innate immunity and the first steps of pathogenesis. (Arend, P., 2018b) , in which this mechanism may be similarly utilized by a non-viral pathogen, such as the protozoan parasite Plasmodium falciparum.

hybridization of the ABO(H) blood groups. This results in the downregulation and/or reduction of the innate anti-ABO(H) isoagglutinin reactivity, exerted by polyreactive nonimmune IgM. In this figure, the virtual, hybrid mucin-type epitopes mimic syngeneic epitopes, which are the targets of this hybridization. The blood group O(H), which is bound to the virus solely by the formation of the hybrid H-type antigen, has the least amount of contact with the pathogen and is the most protected group when it loses only the anti-H, but retains innate anti-A and anti-B isoagglutinin reactivity, involving secondary IgG responses. In blood group A, the anti-A and anti-H formations are physiologically blocked, a decrease in the level of anti-B is observed, and neither anti-A-nor anti-B-reactive IgG is produced. In blood group B, the anti-B and anti Hreactivities are blocked, a decrease in the level of anti A is observed, and, similar to blood group A, neither anti-A nor anti-B-reactive IgG is produced. Blood group AB has the strongest contact to the pathogen and is the least protected group with respect to innate ABO(H) immunity.

The proposed concept of a viral invasion, initiated by the mobilization of the serine molecule from the viral S protein and completed by the formation of a genetically undefined, hybrid A-like/Tn host-pathogen molecular bridge, does not question the established functions of the ACE2 receptor protein based on previous (Wu et al., 2011) and current definitions (Zhou et al., 2020; Armijos-Jaramillo et al., 2020) . Rather, it shows an additional and more specific interaction between host and pathogen.

Both N-and O-glycosylation may occur within this complex pathogenic process, and among multiple chemical and physicochemical linkage options, both trans-species ontogenetic, blood group-independent, and blood group-specific binding may predominantly be performed through O-glycosylation in two different glycosidic steps, dominated by the pathogen's hydrophilic amino acid serine. In addition, a blood group-specific, mucin-type formation appears to elongate and/or replace the transspecies, ontogenetic binding. The prominent evolutionary position of the serine molecule (Willis et al., 2013) may again be revealed in SARS-CoV-2 infection and is evident in other unrelated infectious diseases, such as the serine repeat antigen (SERA) in malaria tropica (Bzik et al., 1988; Aoki et al., 2002; Arisue et al., 2011) and the serine-rich E. histolytica protein (STREHP) of Entamoeba histolytica (Zhang et al., 1994; Stanley et al., 1995) which dictates the binding and virulence of the parasite (Manochitra, 2017) . Moreover, the inhibition of the TMPRSS2 enzyme or the blocking of serine mobilization could be used as a therapeutic strategy against influenza virus (Meyer et al., 2013) and SARS-CoV-2 infections and supports the proposed concept of the pathogenesis of SARS-CoV-2 infection.

Intriguingly, the susceptibility of blood group A individuals to infections with Plasmodium falciparum, the pathogen of malaria tropica, is similar to infections with SARS-CoV-2, and since the ABO(H) phenotype development is molecularly con-nected to the development of humoral innate immunity, it might, in view of the special serine metabolisms in these pathogens, be tempting to speculate that both the viral and the non-viral pathogenesis will be initiated via a hybrid, developmental classical Tn O-glycan.

Again, it is proposed that SARS-CoV-2 infection is initiated via a functional host-pathogen molecular bridge by forming an intermediate and genetically undefined, serologically A-like/Tn structure, which must be differentiated from the human blood group A-specific epitope. This is encoded by the A allele of the ABO gene located on chromosome 9q34, which, together with the B-allele, determines the risk of developing life-threatening diseases in the non-O blood groups (Arend, P., 2020b) . Interactions between different pathogenic viruses and human ABO(H) glycans have been recognized for decades and can be explained by molecular biological models of a similar nature. A human rotavirus interacts with the A-type histo-blood group antigen, and its infectivity is specifically abrogated by anti-A antibodies (Hu et al., 2012b) . Appropriately, the comprehensive study by Guillon et al. (2008) and their analysis of a SARS-CoV-1 outbreak in Hongkong in 2003, demonstrated that blood group O(H) was associated with low risk of infection, while the interaction between the viral S protein and the host cell receptor was inhibited by natural and monoclonal anti-A antibodies in vitro. Finally, the actual and first statistical study of SARS-CoV-2 indicated that individuals with blood group A have a significantly higher risk of acquiring SARS-CoV-2 or COVID-19 infection, whereas people with blood group O have a significantly lower risk of infection compared to non-O blood groups (Zhao et al., 2020) . While this observation awaits confirmation, the central immunological position of the human blood group O(H) might have already become evident in a small study conducted 50 years ago (Arend and Fehlhaber, 1969) and has been widely discussed in recent works (Arend, P., 2017; 2018b; 2018a) .

The individual risk of becoming infected with SARS-CoV-2 or becoming seriously ill cannot be predicted based on a person's ABO(H) blood group affiliation alone because many other risks exist and blood group O(H) is no longer considered a genetic entity (Arend, P., 2016) . Nevertheless, SARS CoV-2 (COVID-19) infection can be regarded as an evolutionary selective disease, contributing to the current global distribution in terms of human blood groups O(H), A, B, and AB, which according to Springer and Wiener (1962) developed over millions of years mainly in connection with ABO(H) blood group-related life-threatening diseases, such as malaria (Cserti and Dzik, 2007; Cserti-Gazdewich, 2010; Arend, P., 2018b; 2020b) .

The synthesis of blood group AB enables the strongest contact with a pathogen and molecularly precludes any isoagglutinin activity, making this group the least protected and the smallest among the ABO(H) blood groups. In contrast, individuals with blood group O(H), which are prone to other infections, especially cholera, have survived all infectious diseases in an immunological balance with many pathogens and remain the largest blood group worldwide despite extensive historical cholera pandemics (Echenberg, 2011; Mutreja et al., 2011; Chowdhury et al., 2017) .

These individuals rarely develop severe diseases classified as blood group A/Brelated infections. They maintain anti-A/Tn cross-reactive and anti-B complementdependent isoagglutinin activities, which are exerted by the polyreactive, nonimmune IgM, which is regarded as the humoral spearhead of innate immunity and the first line of defense. This is the first description of a hypothetical pathogenesis, wherein the contact between host and pathogen is initiated by formation of a hybrid trans-species, developmental A-like/Tn O-glycan, which through its intermediate function plays a key role in the evolution of species and in the human is controlled by innate immunity.

The in this manuscript simplified, hypothetical formation of hybrid ABO(H) blood group-specific epitopes requires further experimental evidence, while the hybrid A-like/Tn structure might become the basis for a new pharmacological and immunological therapeutic target, independent of the ABO(H) blood group phenotype.

None.

The proximal origin of SARS-CoV-2

Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth

ABO (histo) blood group phenotype development and human reproduction as they relate to ancestral IgM formation: A hypothesis

Early ovariectomy reveals the germline encoding of natural anti-A-and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM)

ABO phenotype-protected reproduction based on human specific α1,2 L-fucosylation as explained by the Bombay type formation

Position of human blood group O(H) and phenotype-determining enzymes in growth and infectious disease

How blood group A might be a risk and blood group O be protected from coronavirus (COVID-19) infections (how the virus invades the human body via ABO(H) blood group-determining carbohydrates). figshare, v175

Malaria tropica evades host immunity through ABO blood group hybridization. figshare, v120

Varying influence of increased enteral antigen absorption on the behavior of "natural" antibodies in O and A blood group subjects

Comparative blood group serological studies on patients with ulcerative colitis and healthy persons

Significance of specific ovarian receptors for syngeneic naturally-occurring haemagglutinating anti-A antibodies

Age dependent appearance of A-specific ovarian glycolipids and syngeneic "natural" anti-A hemolysin in mice

A-specific autoantigenic ovarian glycolipids inducing production of "natural" anti-A antibody

Clues to evolution of the SERA multigene family in 18 Plasmodium species

SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability

Alpha2-macroglobulin: an evolutionarily conserved arm of the innate immune system

Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA

Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming

Angiotensin I-converting enzyme (ACE) polymorphism and ABO blood groups as factors codetermining plasma ACE activity

The ABO blood group system and Plasmodium falciparum malaria', Blood

Plasmodium falciparum malaria and carbohydrate blood group evolution

Studies on O-glycans of Plasmodium-falciparum-infected human erythrocytes. Evidence for O-GlcNAc and O-GlcNAc-transferase in malaria parasites

Africa in the time of cholera: a history of pandemics from 1815 to the present (African studies)

Influence of ABO genotype and phenotype on angiotensin-converting enzyme plasma activity

Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies

The Regulation of Inherently Autoreactive VH4-34-Expressing B Cells in Individuals Living in a Malaria-Endemic Area of West Africa

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Spontaneous Production of Immunoglobulin M in Human Epithelial Cancer Cells

Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen

Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail Deleted

Mice are unsuitable for modelling ABO discordance despite strain-specific A cross-reactive natural IgM

Serine-rich repeat proteins from gut microbes

In-silico prediction and modeling of the Entamoeba histolytica proteins: Serine-rich Entamoeba histolytica protein and 29 kDa Cysteine-rich protease

Comparative study of blood grouprecognizing lectins toward ABO blood group antigens on neoglycoproteins, glycoproteins and complex-type oligosaccharides

Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation

Acquired hemolytic anemia with polyagglutinability of erythrocytes by a new factor present in normal blood (Article in French

Evidence for several waves of global transmission in the seventh cholera pandemic

Evidence for several waves of global transmission in the seventh cholera pandemic

Glycosylation of the Severe Acute Respiratory Syndrome Coronavirus Triple-Spanning Membrane Proteins 3a and M

Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement

Plasmodium DNA-mediated TLR9 activation of T-bet+ B cells contributes to autoimmune anaemia during malaria

Epithelial cells are a source of natural IgM that contribute to innate immune responses

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

Alleged causes of the present-day world distribution of the human abo blood groups

The Serine-rich Entamoeba histolytica Protein Is a Phosphorylated Membrane Protein Containing O-Linked Terminal N-Acetylglucosamine Residues

α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum

Molecules and May Facilitate Adhesion of Parasitized Erythrocytes

Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method

Comparative analysis of apicomplexa and genomic diversity in eukaryotes

Quantitative variation in plasma angiotensin-I converting enzyme activity shows allelic heterogeneity in the ABO blood group locus

The O-linked glycome and blood group antigens ABO on mucin-type glycoproteins in mucinous and serous epithelial ovarian tumors

SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway

Emerging functions of natural IgM and its Fc receptor FCMR in immune homeostasis

Transcriptional inhibition of host viral entry proteins as a therapeutic strategy for SARS-CoV-2

Exploitation of glycosylation in enveloped virus pathobiology

Human Germline Antibody Gene Segments Encode Polyspecific Antibodies

A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses

Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice

Relationship between the ABO Blood Group and the COVID-19 Susceptibility. medRxiv

A pneumonia outbreak associated with a new coronavirus of probable bat origin

MicroRNA regulation of innate immune responses in epithelial cells